Information

Sorry, we couldn't match any information with this search.

About us

News & Media

For all media enquiries please contact us

CONTACT US

News + Updates

Loading...

Please wait while we load in the news for you.

Latest News

Douglas selected for FDA’s Quality Management Maturity pilot study

27/06/2024
Quality

R-107 Phase 2 Study Results for Treatment-Resistant Depression Accepted by Leading Scientific Journal, Nature Medicine

25/06/2024
Research

Douglas Pharmaceuticals announces the launch of their new Parental Leave Package

09/05/2024
Careers

Douglas Fiji receives a Recognition Award for Outstanding Achievement at the Prime Minister’s International Business Awards

01/12/2023
Awards

Douglas Pharmaceuticals expands its Contract Development and Manufacturing (CDMO) business

27/10/2023
Manufacturing

Douglas Pharmaceuticals secures US licensing deal to treat high grade cervical dysplasia

27/09/2023
Research

Feeding people, not landfill

03/08/2023
Corporate Responsibility

Douglas Innovation awarded Excellence at the Property Council NZ Awards

06/07/2023
Awards

Douglas People & Culture team win HR Team of the Year

27/04/2023
Awards

Protecting Fiji’s Coastline

01/04/2023
Corporate Responsibility

Formation of Clinical Advisory Board for Lead Program R-107

17/02/2023
Research

Clinicians China licenced to HTDK Pharmaceuticals

03/10/2022
Commercial

New Zealand’s largest medical R&D facility opens in West Auckland

15/09/2022
Commercial

Trial data suggests major breakthrough in Treatment Resistant Depression

17/06/2021
Research

Douglas works with 75 year old inventor to create easy to us spray pump for those with arthritis

23/04/2020
Large Dispensers

Douglas wins Best Large Business in the New Zealand International Business Awards

07/11/2019
Awards

Douglas Pharmaceutical’s Chief Scientific Officer talks about a new drug for treatment resistant depression

28/05/2019
Large Dispensers

Douglas Pharmaceuticals begins work on $35MM Research and Development building

23/04/2019
Commercial

Douglas Pharmaceuticals tackles treatment-resistant depression

22/01/2019
Research

New Zealand children to benefit from $9 million gift to Starship

06/12/2018
Corporate Responsibility

For all media enquiries please contact us

CONTACT US